Testing effectiveness (Phase 2)Ended earlyNCT01934894
What this trial is testing
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
Who this might be right for
Metastatic Breast Cancer With Intracranial Metastases
SCRI Development Innovations, LLC 11